Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04343898 · ClinicalTrials.gov registry record
Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 5,154
- Enrollment target
NCT04343898: Completed study, sponsored by Brigham and Women's Hospital.
NCT04343898 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 5,154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04343898 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 5,154 participants
- Enrollment target
Study Summary
Multicenter observational/registry study of the clinical features and outcomes of critically ill patients with COVID-19.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,154 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2023-07-01 |
What the finished NCT04343898 record still lists
NCT04343898 is an observational study that tracks outcomes without assigning an intervention. Its 5,154 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04343898 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04343898 about?
NCT04343898 is a clinical study titled "Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19". Multicenter observational/registry study of the clinical features and outcomes of critically ill patients with COVID-19.
What is the current status of trial NCT04343898?
This trial is currently completed. The enrollment target is 5,154 participants. The study started on 2020-04-01. Estimated completion is 2023-07-01.
What interventions are being tested in trial NCT04343898?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04343898?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05135403 · 5,179 participants
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
- NCT06535867 · 5,122 participants
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
- NCT06008197 · 5,200 participants · Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI